References
- Wu Y, Hu H, Cai J, et al. Association of mean arterial pressure with 5-year risk of incident diabetes in Chinese adults: a secondary population-based cohort study. BMJ Open. 2022 Sep 19;12(9):e048194. doi: 10.1136/bmjopen-2020-048194
- Zhang Y, Hu G, Zhang L, et al. A novel testing model for opportunistic screening of pre-diabetes and diabetes among US adults. PLoS One. 2015;10(3):e0120382.
- Farah RI, Al-Sabbagh MQ, Momani MS, et al. Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study. BMC Nephrol. 2021 Jun 16;22(1):223. doi: 10.1186/s12882-021-02429-4
- Bishu KG, Jenkins C, Yebyo HG, et al. Diabetes in Ethiopia: a systematic review of prevalence, risk factors, complications, and cost. Obes Med. 2019 Sep 01;15:100132.
- Murphy-Chutorian B, Han G, Cohen SR. Dermatologic manifestations of diabetes mellitus: a review. Endocrinol Metab Clin North Am. 2013;42(4):869–898. doi: 10.1016/j.ecl.2013.07.004
- Vanstone M, Rewegan A, Brundisini F, et al. Patient perspectives on quality of life with uncontrolled type 1 diabetes mellitus: a systematic review and qualitative meta-synthesis. Ont Health Technol Assess Ser. 2015;15(17):1.
- Hong J, Xin S, Min R, et al. The tryptic peptides of hemoglobin for diagnosis of type 2 diabetes mellitus using label-free and standard-free LC-ESI-DMRM. Redox Biol. 2021 Jul 01;43:101985.
- Yazdanpanah S, Rabiee M, Tahriri M, et al. Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: a comprehensive review. Crit Rev Clin Lab Sci. 2017;54(4):219–232.
- de Oliveira Alvim R, Mourao-Junior CA, de Oliveira CM, et al. Glycemic control and arterial stiffness in a Brazilian rural population: Baependi Heart Study. Diabetol Metab Syndr. 2015;7(1):1–6.
- Nanayakkara N, Curtis AJ, Heritier S, et al. Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses. Diabetologia. 2021 Feb 01;64(2):275–287. doi: 10.1007/s00125-020-05319-w
- Uk ICrsm-eca. The link between family history and risk of type 2 diabetes is not explained by anthropometric, lifestyle or genetic risk factors: the EPIC-InterAct study. Diabetologia. 2013;56(1):60–69. doi: 10.1007/s00125-012-2715-x
- Drong A, Lindgren C, McCarthy M. The genetic and epigenetic basis of type 2 diabetes and obesity. Clin Pharmacol Ther. 2012;92(6):707–715. doi: 10.1038/clpt.2012.149
- Bi Y, Wang T, Xu M, et al. Advanced research on risk factors of type 2 diabetes. Diabetes Metab Res Rev. 2012;28:32–39. doi: 10.1002/dmrr.2352
- Henríquez-Hernández LA, Luzardo OP, Valerón PF, et al. Persistent organic pollutants and risk of diabetes and obesity on healthy adults: results from a cross-sectional study in Spain. Sci Total Environ. 2017 Dec 31;607-608:1096–1102.
- Shahwan MJ, Khattab AH, Khattab MH, et al. Association between abnormal serum hepatic enzymes, lipid levels and glycemic control in patients with type 2 diabetes mellitus. Obes Med. 2019 Dec 01;16:100137.
- Herath HMM, Kodikara I, Weerarathna TP, et al. Prevalence and associations of non-alcoholic fatty liver disease (NAFLD) in Sri Lankan patients with type 2 diabetes: a single center study. Diabetes Metab Syndr. 2019 Oct 01;13(1):246–250. doi: 10.1016/j.dsx.2018.09.002
- Nuttall FQ, Ngo A, Gannon MC. Regulation of hepatic glucose production and the role of gluconeogenesis in humans: is the rate of gluconeogenesis constant? Diabetes Metab Res Rev. 2008;24(6):438–458. doi: 10.1002/dmrr.863
- Cefalu WT. Medical management of diabetes mellitus. CRC Press; 2000.
- Shubrook J. Everyday diabetes in primary care: a case-based approach. Wolters Kluwer Health and Lippincott Williams & Wilkins; 2023.
- Alam S, Raghav A, Reyaz A, et al. Prevalence of elevated liver enzymes and its relationship with type 2 diabetes mellitus in North Indian adults. Metabolism Open. 2021 Dec 01;12:100130.
- Khafagy GM, Darwish HA, Yosry A, et al. Non alcoholic fatty liver disease and degree of steatosis in diabetic and non-diabetic patients. Obes Med. 2020;19:100243. doi: 10.1016/j.obmed.2020.100243
- Ozder A. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study. Lipids Health Dis. 2014 Dec 06;13(1):183.
- Belkacemi L, Belalia M. Cross-sectional pilot study about the liver enzymes profile in type 2 diabetic patients from an Algerian west region: wilaya of Mostaganem. Diabetes Metab Syndr. 2016 Jan 01;10(Supplement 1):S147–S150.
- West J, Brousil J, Gazis A, et al. Elevated serum alanine transaminase in patients with type 1 or type 2 diabetes mellitus. QJM. 2006;99(12):871–876.
- Judi L, Toukan A, Khader Y, et al. Prevalence of elevated hepatic transaminases among Jordanian patients with type 2 diabetes mellitus [article]. Ann Saudi Med. 2010;30(1):25–32.
- Ciarambino T, Crispino P, Leto G, et al. Influence of gender in diabetes mellitus and its complication. Int J Mol Sci. 2022;23(16):8850.
- Khafagy GM, Darwish HA, Yosry A, et al. Non alcoholic fatty liver disease and degree of steatosis in diabetic and non- diabetic patients. Obes Med. 2020 Sep 01;19:100243.
- Islam S, Rahman S, Haque T, et al. Prevalence of elevated liver enzymes and its association with type 2 diabetes: a cross-sectional study in Bangladeshi adults. Endocrinol Diabetes Metab. 2020 Apr;3(2):e00116. doi: 10.1002/edm2.116
- Tohidi M, Harati H, Hadaegh F, et al. Association of liver enzymes with incident type 2 diabetes: a nested case control study in an Iranian population. BMC Endocr Disord. 2008 Jun 05;8(1):5. doi: 10.1186/1472-6823-8-5
- Jalilian M, Rasad R, Rotbeh A. Fatty liver disease in overweight and obese Iranian children: comprehensive systematic review and meta-analysis. Obes Med. 2022 Oct 01;35:100455. doi: 10.1016/j.obmed.2022.100455